Search PubMed⌕ Search

Biomedical subjects

D Stevens

Publications and source records attributed to D Stevens.

116 records · Page 7Linked to original sources

Observations on the sonographic measurement of cervical length and the risk of premature birth.

OBJECTIVE: There is increasing evidence that sonographic measurement of cervical length may be a useful predictor of the risk of spontaneous premature birth. The purpose of this study is to determine whether the measurement of cervical length in a high-risk population at 24 weeks gestation, or the relative change over 24-28 weeks gestation, is more accurate in predicting the risk of spontaneous preterm birth before 35 weeks gestation. METHODS: Over a 4-year period from 1993-1996, 443 patients with a singleton pregnancy who were at increased risk of preterm birth were studied by serial endovaginal sonography performed at 24 and 28 weeks gestation. RESULTS: There was a positive association between a short cervix and increased risk of preterm birth (F = 13.3, P < .0001). The variable with the highest predictive value for preterm birth was the cervical length at 24 weeks gestation. Changes over time did not substantially improve the predictive accuracy for spontaneous preterm birth. CONCLUSIONS: We conclude that a short cervix as determined by endovaginal sonography has a significant association with preterm birth in a high-risk obstetric population. Measurements taken at 24 weeks gestation are most accurate in assessing this risk, and serial observations of the cervix over time have less accuracy for predicting preterm birth.

Adult↗

"Ultrasound swallow".

Explore the source record for details and available documents.

Deglutition↗

Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.

PURPOSE: Interferon-alfa, 2'-deoxycoformycin, and 2-chlorodeoxy-adenosine (2-CdA) are effective in the management of patients with hairy cell leukemia. These agents produce remissions in most patients, but relapses occur with all three drugs. The optimal means to follow patients for relapse after treatment has not been determined. METHODS: We retrospectively examined serial serum soluble interleukin-2 receptor levels (sIL-2R) and absolute granulocyte counts in eight patients with relapsed hairy cell leukemia. All were treated with 2-CdA at the time of relapse. Serum samples were available at 3- to 6-month intervals from 5 to 9 years before relapse and 2-CdA treatment RESULTS: sIL-2R levels increase only in patients who go on to relapse. sIL-2R levels doubled a mean of 17.1 months (range, 4-36 months) before absolute granulocyte count decreased by 50%. DISCUSSION: Demonstration of a rising serum sIL-2R level in patients with hairy cell leukemia identified those with an increased risk of relapse who need more frequent observation than patients who maintain a stable sIL-2R level. Early intervention may ameliorate the toxicity of salvage therapy because disease-related neutropenia may be anticipated.

Antineoplastic Agents↗